Effect of milrinone on the inflammatory response and NF-kB activation in renal ischemia-reperfusion injury in mice
Milrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a key role in inflammatory responses during ischemia-reperfusion (I/R) injury. We aimed to investigate the effect of milrinone on the...
Saved in:
Published in | Korean journal of anesthesiology Vol. 66; no. 2; pp. 136 - 142 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Society of Anesthesiologists
01.02.2014
Korean Society of Anesthesiologists 대한마취통증의학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2005-6419 2005-7563 |
DOI | 10.4097/kjae.2014.66.2.136 |
Cover
Abstract | Milrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a key role in inflammatory responses during ischemia-reperfusion (I/R) injury. We aimed to investigate the effect of milrinone on the inflammatory responses and NF-kB activation in renal I/R injury in mice.
Thirty C57BL/6 mice were allocated into 3 groups. In group S (n = 10), only right nephrectomy was done. In group C (n = 10), the left kidney was subjected to 30 min of ischemia after right nephrectomy. In group M (n = 10), milrinone (5 µg/kg) was administered before ischemia. After 24 hours of reperfusion, the serum creatinine was measured, kidney samples were obtained for histology, and expressions of NF-kB and proinflammatory cytokines were analyzed.
In group C, the serum creatinine concentration was markedly elevated, compared with group S. Creatinine concentration in group M was also elevated, but it was significantly lower than that in group C. Histologic evidence of renal damage was severe in group C, but it was improved in group M. In groups C and M, expression of NF-kB, tumor necrosis factor-α (TNF-α), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-2) mRNA increased significantly compared with group S (P < 0.05). But group M showed a lower expression of NF-kB, TNF-α, ICAM-1, MCP-1 and MIP-2 mRNA than group C (P < 0.05).
Milrinone treatment attenuates the renal inflammatory response and activation of NF-kB, resulting in improvement of renal function and tissue injury. |
---|---|
AbstractList | BackgroundMilrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a key role in inflammatory responses during ischemia-reperfusion (I/R) injury. We aimed to investigate the effect of milrinone on the inflammatory responses and NF-kB activation in renal I/R injury in mice.MethodsThirty C57BL/6 mice were allocated into 3 groups. In group S (n = 10), only right nephrectomy was done. In group C (n = 10), the left kidney was subjected to 30 min of ischemia after right nephrectomy. In group M (n = 10), milrinone (5 µg/kg) was administered before ischemia. After 24 hours of reperfusion, the serum creatinine was measured, kidney samples were obtained for histology, and expressions of NF-kB and proinflammatory cytokines were analyzed.ResultsIn group C, the serum creatinine concentration was markedly elevated, compared with group S. Creatinine concentration in group M was also elevated, but it was significantly lower than that in group C. Histologic evidence of renal damage was severe in group C, but it was improved in group M. In groups C and M, expression of NF-kB, tumor necrosis factor-α (TNF-α), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-2) mRNA increased significantly compared with group S (P < 0.05). But group M showed a lower expression of NF-kB, TNF-α, ICAM-1, MCP-1 and MIP-2 mRNA than group C (P < 0.05).ConclusionsMilrinone treatment attenuates the renal inflammatory response and activation of NF-kB, resulting in improvement of renal function and tissue injury. Background: Milrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a key role in inflammatory responses during ischemia-reperfusion (I/R) injury. We aimed to investigate the effect of milrinone on the inflammatory responses and NF-kB activation in renal I/R injury in mice. Methods: Thirty C57BL/6 mice were allocated into 3 groups. In group S (n = 10), only right nephrectomy was done. In group C (n = 10), the left kidney was subjected to 30 min of ischemia after right nephrectomy. In group M (n = 10), milrinone (5 μg/kg) was administered before ischemia. After 24 hours of reperfusion, the serum creatinine was measured, kidney samples were obtained for histology, and expressions of NF-kB and proinflammatory cytokines were analyzed. Results: In group C, the serum creatinine concentration was markedly elevated, compared with group S. Creatinine concentration in group M was also elevated, but it was significantly lower than that in group C. Histologic evidence of renal damage was severe in group C, but it was improved in group M. In groups C and M, expression of NF-kB, tumor necrosis factor-α (TNF-α), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-2) mRNA increased significantly compared with group S (P < 0.05). But group M showed a lower expression of NF-kB, TNF-α, ICAM-1, MCP-1 and MIP-2 mRNA than group C (P < 0.05). Conclusions: Milrinone treatment attenuates the renal inflammatory response and activation of NF-kB, resulting in improvement of renal function and tissue injury. KCI Citation Count: 1 Milrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a key role in inflammatory responses during ischemia-reperfusion (I/R) injury. We aimed to investigate the effect of milrinone on the inflammatory responses and NF-kB activation in renal I/R injury in mice.BACKGROUNDMilrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a key role in inflammatory responses during ischemia-reperfusion (I/R) injury. We aimed to investigate the effect of milrinone on the inflammatory responses and NF-kB activation in renal I/R injury in mice.Thirty C57BL/6 mice were allocated into 3 groups. In group S (n = 10), only right nephrectomy was done. In group C (n = 10), the left kidney was subjected to 30 min of ischemia after right nephrectomy. In group M (n = 10), milrinone (5 µg/kg) was administered before ischemia. After 24 hours of reperfusion, the serum creatinine was measured, kidney samples were obtained for histology, and expressions of NF-kB and proinflammatory cytokines were analyzed.METHODSThirty C57BL/6 mice were allocated into 3 groups. In group S (n = 10), only right nephrectomy was done. In group C (n = 10), the left kidney was subjected to 30 min of ischemia after right nephrectomy. In group M (n = 10), milrinone (5 µg/kg) was administered before ischemia. After 24 hours of reperfusion, the serum creatinine was measured, kidney samples were obtained for histology, and expressions of NF-kB and proinflammatory cytokines were analyzed.In group C, the serum creatinine concentration was markedly elevated, compared with group S. Creatinine concentration in group M was also elevated, but it was significantly lower than that in group C. Histologic evidence of renal damage was severe in group C, but it was improved in group M. In groups C and M, expression of NF-kB, tumor necrosis factor-α (TNF-α), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-2) mRNA increased significantly compared with group S (P < 0.05). But group M showed a lower expression of NF-kB, TNF-α, ICAM-1, MCP-1 and MIP-2 mRNA than group C (P < 0.05).RESULTSIn group C, the serum creatinine concentration was markedly elevated, compared with group S. Creatinine concentration in group M was also elevated, but it was significantly lower than that in group C. Histologic evidence of renal damage was severe in group C, but it was improved in group M. In groups C and M, expression of NF-kB, tumor necrosis factor-α (TNF-α), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-2) mRNA increased significantly compared with group S (P < 0.05). But group M showed a lower expression of NF-kB, TNF-α, ICAM-1, MCP-1 and MIP-2 mRNA than group C (P < 0.05).Milrinone treatment attenuates the renal inflammatory response and activation of NF-kB, resulting in improvement of renal function and tissue injury.CONCLUSIONSMilrinone treatment attenuates the renal inflammatory response and activation of NF-kB, resulting in improvement of renal function and tissue injury. Milrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a key role in inflammatory responses during ischemia-reperfusion (I/R) injury. We aimed to investigate the effect of milrinone on the inflammatory responses and NF-kB activation in renal I/R injury in mice. Thirty C57BL/6 mice were allocated into 3 groups. In group S (n = 10), only right nephrectomy was done. In group C (n = 10), the left kidney was subjected to 30 min of ischemia after right nephrectomy. In group M (n = 10), milrinone (5 µg/kg) was administered before ischemia. After 24 hours of reperfusion, the serum creatinine was measured, kidney samples were obtained for histology, and expressions of NF-kB and proinflammatory cytokines were analyzed. In group C, the serum creatinine concentration was markedly elevated, compared with group S. Creatinine concentration in group M was also elevated, but it was significantly lower than that in group C. Histologic evidence of renal damage was severe in group C, but it was improved in group M. In groups C and M, expression of NF-kB, tumor necrosis factor-α (TNF-α), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-2) mRNA increased significantly compared with group S (P < 0.05). But group M showed a lower expression of NF-kB, TNF-α, ICAM-1, MCP-1 and MIP-2 mRNA than group C (P < 0.05). Milrinone treatment attenuates the renal inflammatory response and activation of NF-kB, resulting in improvement of renal function and tissue injury. |
Author | Jung, Hong Soo Kim, Dae-Woo In, Jang Hyeok Roh, Misun Joo, Jin-Deok Choi, Jin Woo Jeong, Jong-Tae Noh, Seung June |
AuthorAffiliation | 1 Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea 2 The Research Institute of Medical Science, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea |
AuthorAffiliation_xml | – name: 2 The Research Institute of Medical Science, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea – name: 1 Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea |
Author_xml | – sequence: 1 givenname: Hong Soo surname: Jung fullname: Jung, Hong Soo organization: Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea – sequence: 2 givenname: Jin-Deok surname: Joo fullname: Joo, Jin-Deok organization: Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea – sequence: 3 givenname: Dae-Woo surname: Kim fullname: Kim, Dae-Woo organization: Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea – sequence: 4 givenname: Jang Hyeok surname: In fullname: In, Jang Hyeok organization: Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea – sequence: 5 givenname: Misun surname: Roh fullname: Roh, Misun organization: Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea – sequence: 6 givenname: Jong-Tae surname: Jeong fullname: Jeong, Jong-Tae organization: Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea – sequence: 7 givenname: Seung June surname: Noh fullname: Noh, Seung June organization: The Research Institute of Medical Science, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea – sequence: 8 givenname: Jin Woo surname: Choi fullname: Choi, Jin Woo organization: Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24624272$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001851038$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9kk1v1DAQhiNUREvpH-CAcuSSrb9iJxekUrWwUgUSKmdr4oy73k3sxc5W6r_Hu2kL5YAvY3meeeeVZ94WRz54LIr3lCwEadX5Zg24YISKhZQLtqBcvipOGCF1pWrJjx7vUtD2uDhLaU3y4ZwQyd4Ux0xIJphiJ0W8shbNVAZbjm6Ibt-lDL6cVlg6bwcYR5hCfCgjpm3wCUvwffntutp8LsFM7h4ml3HnM-BhKF0yKxwdVBG3GO0uzdn1LktkaHQG3xWvLQwJzx7jafHz-ur28mt18_3L8vLipjK1VFOF1IhsWEmkIDpuaNta1pmul8wo3nfAuDKk71jLmcHWUsulIH3dKEUIo4qfFh9nXR-t3hinA7hDvAt6E_XFj9ulVqymNcnockb7AGu9jW6E-HDgDw8h3mmIkzMDagkEul4hsdiIBgSwviG26QD6RlnArPVp1truuhF7g36KMLwQfZnxbpUt3WveikYI-sf3NoZfO0yTHvOv4jCAx7BLOhtWqhWtYBn98Hev5yZP880AmwETQ0oR7TNCid7vkd7vkd7vkZZSM533KBc1_xQZNx3mnP264X-lvwG7nc_1 |
CitedBy_id | crossref_primary_10_1016_j_tox_2015_10_010 crossref_primary_10_1038_ncomms14181 crossref_primary_10_1007_s00405_019_05417_5 crossref_primary_10_1097_WNR_0000000000000419 crossref_primary_10_3389_fphar_2021_561237 crossref_primary_10_1016_j_lfs_2023_121435 crossref_primary_10_1038_s41401_018_0160_1 crossref_primary_10_1039_D1MD00131K crossref_primary_10_1097_WNR_0000000000000618 crossref_primary_10_3390_biom11101549 crossref_primary_10_4097_kjae_2014_66_2_93 crossref_primary_10_1080_08941939_2017_1343880 crossref_primary_10_1177_1535370219855399 crossref_primary_10_1016_j_avsg_2020_06_050 crossref_primary_10_1016_j_toxlet_2018_05_003 crossref_primary_10_2147_DDDT_S267856 crossref_primary_10_1155_2021_9098145 crossref_primary_10_1016_j_lfs_2021_119843 crossref_primary_10_1080_00207454_2023_2286209 crossref_primary_10_1016_j_intimp_2016_08_032 crossref_primary_10_1111_and_14128 crossref_primary_10_1371_journal_pone_0117004 crossref_primary_10_1016_j_gene_2016_12_026 crossref_primary_10_18632_aging_202889 crossref_primary_10_1016_j_lfs_2022_120799 crossref_primary_10_1016_j_wneu_2020_12_021 crossref_primary_10_15407_ubj93_01_051 crossref_primary_10_1016_j_transproceed_2016_11_043 crossref_primary_10_1007_s00210_023_02476_8 crossref_primary_10_1590_1517_869220172303159519 crossref_primary_10_3390_molecules25081817 crossref_primary_10_1016_j_pharmthera_2016_03_015 crossref_primary_10_2147_NDT_S240698 crossref_primary_10_1053_j_jvca_2018_04_032 crossref_primary_10_1016_j_toxrep_2015_07_019 crossref_primary_10_1093_jpp_rgaf002 |
Cites_doi | 10.3109/00365513.2013.796591 10.1016/0888-6296(90)90226-6 10.1016/j.jss.2008.07.004 10.1002/hep.21497 10.1152/ajpheart.00796.2000 10.1016/S0006-2952(02)01523-X 10.1016/j.jss.2006.05.038 10.1055/s-0038-1655981 10.1016/j.bbrc.2006.10.006 10.1038/sj.bjp.0706495 10.1096/fj.01-0739fje 10.1097/00007890-198303000-00002 10.1172/JCI119457 10.1016/S0022-5347(17)42037-4 10.4097/kjae.2007.53.2.229 10.1152/ajplung.00429.2002 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6 10.1186/1479-5876-7-67 10.1016/j.transproceed.2011.03.009 10.1152/ajplung.00539.2005 10.1097/00003246-200201001-00003 10.1111/j.1478-3231.2006.01327.x 10.1074/jbc.M111.225631 10.1038/cr.2009.137 |
ContentType | Journal Article |
Copyright | Copyright © the Korean Society of Anesthesiologists, 2014 2014 |
Copyright_xml | – notice: Copyright © the Korean Society of Anesthesiologists, 2014 2014 |
DBID | AAYXX CITATION NPM 7X8 5PM DOA ACYCR |
DOI | 10.4097/kjae.2014.66.2.136 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2005-7563 |
EndPage | 142 |
ExternalDocumentID | oai_kci_go_kr_ARTI_725150 oai_doaj_org_article_6a0abd7e0fe848a4a2d80f8baad87fae PMC3948441 24624272 10_4097_kjae_2014_66_2_136 |
Genre | Journal Article |
GrantInformation_xml | – fundername: The St. Vincent's hospital, research institute of medical science, Korea |
GroupedDBID | 5-W 53G 8JR 8XY 9ZL AAYXX ABDBF ACUHS ADRAZ ALMA_UNASSIGNED_HOLDINGS CITATION DIK E3Z EBD EF. ESX F5P GROUPED_DOAJ HYE KQ8 M48 O5R O5S OK1 PGMZT RPM TUS NPM 7X8 5PM ACYCR |
ID | FETCH-LOGICAL-c567t-e1c433076e1a4b3c199f2bcbd62c73dba237c0db2932ce9f1f3640d5877002173 |
IEDL.DBID | M48 |
ISSN | 2005-6419 |
IngestDate | Sun Mar 09 07:51:11 EDT 2025 Wed Aug 27 01:20:54 EDT 2025 Thu Aug 21 17:40:36 EDT 2025 Thu Jul 10 22:39:57 EDT 2025 Mon Jul 21 06:07:19 EDT 2025 Tue Jul 01 02:43:50 EDT 2025 Thu Apr 24 23:07:35 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Ischemia-reperfusion injury Milrinone Nuclear-factor-kappa B |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c567t-e1c433076e1a4b3c199f2bcbd62c73dba237c0db2932ce9f1f3640d5877002173 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-000679.2014.66.2.006 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.4097/kjae.2014.66.2.136 |
PMID | 24624272 |
PQID | 1507794942 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_725150 doaj_primary_oai_doaj_org_article_6a0abd7e0fe848a4a2d80f8baad87fae pubmedcentral_primary_oai_pubmedcentral_nih_gov_3948441 proquest_miscellaneous_1507794942 pubmed_primary_24624272 crossref_primary_10_4097_kjae_2014_66_2_136 crossref_citationtrail_10_4097_kjae_2014_66_2_136 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-02-01 |
PublicationDateYYYYMMDD | 2014-02-01 |
PublicationDate_xml | – month: 02 year: 2014 text: 2014-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Korean journal of anesthesiology |
PublicationTitleAlternate | Korean J Anesthesiol |
PublicationYear | 2014 |
Publisher | The Korean Society of Anesthesiologists Korean Society of Anesthesiologists 대한마취통증의학회 |
Publisher_xml | – name: The Korean Society of Anesthesiologists – name: Korean Society of Anesthesiologists – name: 대한마취통증의학회 |
References | Fan (10.4097/kjae.2014.66.2.136_ref2) 2002; 282 Lanfear (10.4097/kjae.2014.66.2.136_ref7) 2009; 7 Nishiki (10.4097/kjae.2014.66.2.136_ref8) 2011; 43 Satoh (10.4097/kjae.2014.66.2.136_ref12) 2009; 155 Lalor (10.4097/kjae.2014.66.2.136_ref19) 2007; 45 Wan (10.4097/kjae.2014.66.2.136_ref3) 2010; 20 Levy (10.4097/kjae.2014.66.2.136_ref10) 1990; 4 Wright (10.4097/kjae.2014.66.2.136_ref25) 2007; 292 Semmler (10.4097/kjae.2014.66.2.136_ref17) 1993; 78 Comerford (10.4097/kjae.2014.66.2.136_ref14) 2002; 16 Carden (10.4097/kjae.2014.66.2.136_ref21) 2000; 190 Lee (10.4097/kjae.2014.66.2.136_ref24) 2006; 351 Rodríguez (10.4097/kjae.2014.66.2.136_ref26) 2011; 286 Joo (10.4097/kjae.2014.66.2.136_ref1) 2007; 53 Schäfer (10.4097/kjae.2014.66.2.136_ref15) 2003; 65 Bombeli (10.4097/kjae.2014.66.2.136_ref20) 1997; 77 McDougal (10.4097/kjae.2014.66.2.136_ref23) 1988; 140 Boswell-Smith (10.4097/kjae.2014.66.2.136_ref6) 2006; 147 Qiao (10.4097/kjae.2014.66.2.136_ref16) 2003; 284 Craciun (10.4097/kjae.2014.66.2.136_ref13) 2013; 73 Kume (10.4097/kjae.2014.66.2.136_ref11) 2006; 136 Jablonski (10.4097/kjae.2014.66.2.136_ref9) 1983; 35 Takada (10.4097/kjae.2014.66.2.136_ref22) 1997; 99 Senftleben (10.4097/kjae.2014.66.2.136_ref5) 2002; 30 Häcker (10.4097/kjae.2014.66.2.136_ref4) 2006; 357 Jaeschke (10.4097/kjae.2014.66.2.136_ref18) 2006; 26 19640280 - J Transl Med. 2009 Jul 29;7:67 17045613 - J Surg Res. 2006 Dec;136(2):209-18 11959643 - Am J Physiol Heart Circ Physiol. 2002 May;282(5):H1778-86 10685060 - J Pathol. 2000 Feb;190(3):255-66 9169498 - J Clin Invest. 1997 Jun 1;99(11):2682-90 9065986 - Thromb Haemost. 1997 Mar;77(3):408-23 21558270 - J Biol Chem. 2011 Jul 1;286(26):22814-24 8388363 - Immunology. 1993 Apr;78(4):520-5 11782557 - Crit Care Med. 2002 Jan;30(1 Suppl):S18-26 3057220 - J Urol. 1988 Dec;140(6):1325-30 19111324 - J Surg Res. 2009 Jul;155(1):32-9 19997086 - Cell Res. 2010 Jan;20(1):24-33 16402111 - Br J Pharmacol. 2006 Jan;147 Suppl 1:S252-7 6340272 - Transplantation. 1983 Mar;35(3):198-204 23713554 - Scand J Clin Lab Invest. 2013 Aug;73(5):407-13 17256751 - Hepatology. 2007 Feb;45(2):465-74 21693223 - Transplant Proc. 2011 Jun;43(5):1489-94 16905636 - Am J Physiol Lung Cell Mol Physiol. 2007 Jan;292(1):L125-33 12588708 - Am J Physiol Lung Cell Mol Physiol. 2003 Jun;284(6):L972-80 17052690 - Biochem Biophys Res Commun. 2006 Dec 8;351(1):118-25 12527332 - Biochem Pharmacol. 2003 Feb 1;65(3):397-405 16953830 - Liver Int. 2006 Oct;26(8):912-9 17047224 - Sci STKE. 2006 Oct 17;2006(357):re13 11919161 - FASEB J. 2002 Apr;16(6):583-5 |
References_xml | – volume: 73 start-page: 407 year: 2013 ident: 10.4097/kjae.2014.66.2.136_ref13 publication-title: Scand J Clin Lab Invest doi: 10.3109/00365513.2013.796591 – volume: 4 start-page: 7 issue: Suppl 5 year: 1990 ident: 10.4097/kjae.2014.66.2.136_ref10 publication-title: J Cardiothorac Anesth doi: 10.1016/0888-6296(90)90226-6 – volume: 155 start-page: 32 year: 2009 ident: 10.4097/kjae.2014.66.2.136_ref12 publication-title: J Surg Res doi: 10.1016/j.jss.2008.07.004 – volume: 45 start-page: 465 year: 2007 ident: 10.4097/kjae.2014.66.2.136_ref19 publication-title: Hepatology doi: 10.1002/hep.21497 – volume: 78 start-page: 520 year: 1993 ident: 10.4097/kjae.2014.66.2.136_ref17 publication-title: Immunology – volume: 282 start-page: H1778 year: 2002 ident: 10.4097/kjae.2014.66.2.136_ref2 publication-title: Am J Physiol Heart Circ Physiol doi: 10.1152/ajpheart.00796.2000 – volume: 65 start-page: 397 year: 2003 ident: 10.4097/kjae.2014.66.2.136_ref15 publication-title: Biochem Pharmacol doi: 10.1016/S0006-2952(02)01523-X – volume: 136 start-page: 209 year: 2006 ident: 10.4097/kjae.2014.66.2.136_ref11 publication-title: J Surg Res doi: 10.1016/j.jss.2006.05.038 – volume: 77 start-page: 408 year: 1997 ident: 10.4097/kjae.2014.66.2.136_ref20 publication-title: Thromb Haemost doi: 10.1055/s-0038-1655981 – volume: 351 start-page: 118 year: 2006 ident: 10.4097/kjae.2014.66.2.136_ref24 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2006.10.006 – volume: 147 start-page: S252 issue: Suppl 1 year: 2006 ident: 10.4097/kjae.2014.66.2.136_ref6 publication-title: Br J Pharmacol doi: 10.1038/sj.bjp.0706495 – volume: 16 start-page: 583 year: 2002 ident: 10.4097/kjae.2014.66.2.136_ref14 publication-title: FASEB J doi: 10.1096/fj.01-0739fje – volume: 35 start-page: 198 year: 1983 ident: 10.4097/kjae.2014.66.2.136_ref9 publication-title: Transplantation doi: 10.1097/00007890-198303000-00002 – volume: 99 start-page: 2682 year: 1997 ident: 10.4097/kjae.2014.66.2.136_ref22 publication-title: J Clin Invest doi: 10.1172/JCI119457 – volume: 140 start-page: 1325 year: 1988 ident: 10.4097/kjae.2014.66.2.136_ref23 publication-title: J Urol doi: 10.1016/S0022-5347(17)42037-4 – volume: 53 start-page: 229 year: 2007 ident: 10.4097/kjae.2014.66.2.136_ref1 publication-title: Korean J Anesthesiol doi: 10.4097/kjae.2007.53.2.229 – volume: 284 start-page: L972 year: 2003 ident: 10.4097/kjae.2014.66.2.136_ref16 publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00429.2002 – volume: 190 start-page: 255 year: 2000 ident: 10.4097/kjae.2014.66.2.136_ref21 publication-title: J Pathol doi: 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6 – volume: 7 start-page: 67 year: 2009 ident: 10.4097/kjae.2014.66.2.136_ref7 publication-title: J Transl Med doi: 10.1186/1479-5876-7-67 – volume: 43 start-page: 1489 year: 2011 ident: 10.4097/kjae.2014.66.2.136_ref8 publication-title: Transplant Proc doi: 10.1016/j.transproceed.2011.03.009 – volume: 292 start-page: L125 year: 2007 ident: 10.4097/kjae.2014.66.2.136_ref25 publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00539.2005 – volume: 357 start-page: re13 year: 2006 ident: 10.4097/kjae.2014.66.2.136_ref4 publication-title: Sci STKE – volume: 30 start-page: S18 issue: 1 Suppl year: 2002 ident: 10.4097/kjae.2014.66.2.136_ref5 publication-title: Crit Care Med doi: 10.1097/00003246-200201001-00003 – volume: 26 start-page: 912 year: 2006 ident: 10.4097/kjae.2014.66.2.136_ref18 publication-title: Liver Int doi: 10.1111/j.1478-3231.2006.01327.x – volume: 286 start-page: 22814 year: 2011 ident: 10.4097/kjae.2014.66.2.136_ref26 publication-title: J Biol Chem doi: 10.1074/jbc.M111.225631 – volume: 20 start-page: 24 year: 2010 ident: 10.4097/kjae.2014.66.2.136_ref3 publication-title: Cell Res doi: 10.1038/cr.2009.137 – reference: 12588708 - Am J Physiol Lung Cell Mol Physiol. 2003 Jun;284(6):L972-80 – reference: 6340272 - Transplantation. 1983 Mar;35(3):198-204 – reference: 17047224 - Sci STKE. 2006 Oct 17;2006(357):re13 – reference: 19111324 - J Surg Res. 2009 Jul;155(1):32-9 – reference: 9169498 - J Clin Invest. 1997 Jun 1;99(11):2682-90 – reference: 8388363 - Immunology. 1993 Apr;78(4):520-5 – reference: 19640280 - J Transl Med. 2009 Jul 29;7:67 – reference: 11782557 - Crit Care Med. 2002 Jan;30(1 Suppl):S18-26 – reference: 11919161 - FASEB J. 2002 Apr;16(6):583-5 – reference: 17256751 - Hepatology. 2007 Feb;45(2):465-74 – reference: 3057220 - J Urol. 1988 Dec;140(6):1325-30 – reference: 21693223 - Transplant Proc. 2011 Jun;43(5):1489-94 – reference: 19997086 - Cell Res. 2010 Jan;20(1):24-33 – reference: 21558270 - J Biol Chem. 2011 Jul 1;286(26):22814-24 – reference: 12527332 - Biochem Pharmacol. 2003 Feb 1;65(3):397-405 – reference: 16953830 - Liver Int. 2006 Oct;26(8):912-9 – reference: 10685060 - J Pathol. 2000 Feb;190(3):255-66 – reference: 17045613 - J Surg Res. 2006 Dec;136(2):209-18 – reference: 9065986 - Thromb Haemost. 1997 Mar;77(3):408-23 – reference: 16905636 - Am J Physiol Lung Cell Mol Physiol. 2007 Jan;292(1):L125-33 – reference: 23713554 - Scand J Clin Lab Invest. 2013 Aug;73(5):407-13 – reference: 17052690 - Biochem Biophys Res Commun. 2006 Dec 8;351(1):118-25 – reference: 11959643 - Am J Physiol Heart Circ Physiol. 2002 May;282(5):H1778-86 – reference: 16402111 - Br J Pharmacol. 2006 Jan;147 Suppl 1:S252-7 |
SSID | ssj0000330062 |
Score | 2.1188679 |
Snippet | Milrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a... BackgroundMilrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB)... Background: Milrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B... |
SourceID | nrf doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 136 |
SubjectTerms | Experimental ischemia-reperfusion injury milrinone nuclear-factor-kappa b 마취과학 |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQiNfyqIzEDaV1HMePY4tYFQ49Uak3y09It5ut0t3_z4y9Xe0iBBdOkeJxZHvG9jfx-BtCPvrYd1nytnE6KXBQtGlc70TDXIoi-xxMDZC9lBdX4tt1f72X6gtjwio9cB24U-mY81EllpMW2gnHo2ZZe-eiVtklXH2ZYXvOVFmDwU1nJZtoodqUojX1xgzSO50ubhwyZLbiRMoTjpFeB7tSIe-HvWac8p9w5-_hk3v70fwpebIFkvSsduAZeZTG52SqZMR0lelyuJ0G8O0TXY0UUB4FUwLtL8upOp1qaGyiboz0ct4szinecKj_Z0EUBPDrA_i-aTm4Zkp3acqb-1p6A4pAIUxl_4Jczb98_3zRbLMqNKGXat2kNggYHSVT64TvQmtM5j74KHlQXfSOdyqw6AEH8JBMbnMnBYu9Vqo4MN1LcoStf02oCUH0XkuFtGCmizomKQIAktDBsqn7GWkfRtWGLeU4Zr64teB6oCYsasKiJqyUllvQxIx82tW5q4Qbf5U-R2XtJJEsu7wAE7JbE7L_MqEZ-QCqtoswlPr4_LGyi8mCS_HVKkCAPQOZB0OwMAHxVMWNabW5t4ioYVEzgs_Iq2oYu-ZwgddvFJSoA5M5aO9hyTj8LCTfnREaoOqb_9HBt-QxjloNNn9HjtbTJr0HLLX2x2Xa_AIeKx7d priority: 102 providerName: Directory of Open Access Journals |
Title | Effect of milrinone on the inflammatory response and NF-kB activation in renal ischemia-reperfusion injury in mice |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24624272 https://www.proquest.com/docview/1507794942 https://pubmed.ncbi.nlm.nih.gov/PMC3948441 https://doaj.org/article/6a0abd7e0fe848a4a2d80f8baad87fae https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001851038 |
Volume | 66 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Korean Journal of Anesthesiology, 2014, 66(2), , pp.136-142 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfGeOEFgfjqGJWReEMpiePYzhNiiGogsScq7c3y58japiNtJfbfc-ekFUUD8RSpviTu3dn-nXP-HSFvrK_KKFiRGRUkBCiqzkxleJab4Hm00dV9guyFOJ_xL5fV5RHZlTsaFLi-M7TDelKzbjH5-eP2PQx4wK8TZGt6N782SHhZ8IkQE4aJW_fIfViZBAZjXwe4n2ZmCN7zVGM0EXAKXtT9OZq_POZgrUqU_rACtV28C43-mVT52yo1fUQeDvCSfuj94TE5Cu0T0vUUxXQV6bJZdA1E_IGuWgrYj8JfBp9Ypm_ttOsTZgM1racX02x-RvHcQ79rC6IggE9vQG1h2ZisCzehi9t133oN5kEhLHD_lMymn759PM-GWguZq4TcZKFwHLQjRSgMt6Ur6joy66wXzMnSW8NK6XJvAR0wF-pYxFLw3FdKyhTWlM_IMfb-BaG1c7yySkgkC6tLr3wQ3AFMcSVMpqoakWKnVe0GInKsh7HQEJCgJTRaQqMltBCaabDEiLzd33PT03D8U_oMjbWXRArt9MOqu9LDiNTC5MZ6GfIYFFeGG-ZVHpU1xisZTRiR12BqPXdNuh-vVys97zQEGp-1BFxY5SCzcwQNwxK_tZg2rLZrjTgbprqasxF53jvGvjuM46EcCS3ywGUO-nvY0jbfE_V3WXMFAPbkP977kjxApfQZ5qfkeNNtwysAUBs7ThsP4zQ2xml_6xdi-xvi |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+milrinone+on+the+inflammatory+response+and+NF-kB+activation+in+renal+ischemia-reperfusion+injury+in+mice&rft.jtitle=Korean+journal+of+anesthesiology&rft.au=Jung%2C+Hong+Soo&rft.au=Joo%2C+Jin-Deok&rft.au=Kim%2C+Dae-Woo&rft.au=In%2C+Jang+Hyeok&rft.date=2014-02-01&rft.issn=2005-6419&rft.volume=66&rft.issue=2&rft.spage=136&rft_id=info:doi/10.4097%2Fkjae.2014.66.2.136&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2005-6419&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2005-6419&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2005-6419&client=summon |